Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

HCW Biologics Q2 EPS $(0.40) Down From $(0.12) YoY, Sales $180.41K Up From $120.41K YoY

Author: Benzinga Newsdesk | August 14, 2024 05:07pm
HCW Biologics (NASDAQ:HCWB) reported quarterly losses of $(0.40) per share. This is a 233.33 percent decrease over losses of $(0.12) per share from the same period last year. The company reported $180.41 thousand in sales this quarter. This is a 49.84 percent increase over sales of $120.41 thousand the same period last year.

Posted In: HCWB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist